Healthcare’s future is becoming increasingly intertwined with artificial intelligence (AI) and what’s known as ‘agentic’ systems, in particular, the realm of infection prevention. These powerful adjuncts, AI and agentic systems, are revolutionizing the way we prevent infections, shifting from a one-size-fits-all, reactive response to a more proactive, patient-specific preventative model. They are achieving this by focusing on real-time surveillance, predictive risk modeling, and well-timed intervention, which collectively improve patient safety outcomes.
To understand the insistent need for such transformation, consider recent statistics from CDC suggesting one in 31 patients in US hospitals, and one in 10 patients globally as per WHO, acquire at least one healthcare-associated infection (HAI). This transfers to over 3 million preventable deaths annually due to unsafe care practices, signifying significant patient suffering, increased costs, extended hospital stays, and needless mortality.
Despite a steady decrease in infection rates since 2011, HAIs remain a prominent patient safety concern. Emerging antibiotic-resistant infections are adding to the problem, making successful treatments increasingly challenging. Legacy infection prevention and control (IPC) systems have typically adopted a ‘reactive’ approach, only triggering containment measures once an infection is lab-confirmed and transmission has already started.
However, the increasing volumes of data and the urgency of staying ahead of health risks have exposed several weaknesses and created operational limitations in these conventional IPC models. AI and agentic AI solutions are stepping in to fill these gaps, enabling a more proactive, efficient, and effective approach to IPC.
These solutions, by leveraging machine learning and advanced data analytics, can identify potential risks early on and prioritize interventions appropriately. This means infections can be identified and contained before any outbreak, necessitating minimal human intervention.
The University of Pittsburgh School of Medicine and Carnegie Mellon University are among the institutions that have already tasted success in deploying AI-driven IPC systems. They successfully combined AI’s machine learning capabilities with whole-genome sequencing, enabling a notably quicker detection of infectious disease outbreaks within a hospital setting.
However, successfully deploying AI-based solutions demands more than just IT prowess. It involves comprehensive organizational transformation, governance systems, model transparency, and integration with clinical practice. It also demands careful evaluation of strategic deployment models. While leveraging proven AI platforms with local model refinement is often the most practical approach, it requires highly skilled software developers.
It’s crucial to note, the objective of introducing AI in IPC is not to replace IPC professionals, but to strengthen their capabilities. By efficiently turning fragmented hospital data into actionable intelligence, AI empowers IPC teams to intervene earlier, helping prevent escalations into full-blown outbreaks.
So, the future of IPC does not rest on how swiftly we react to outbreaks, but on how effectively we prevent them from occurring in the first place, and AI is steering this paradigm shift.